CLDX
Celldex Therapeutics Inc.
$25.17
+$0.51(+2.07%)
48
Overall
60
Value
36
Tech
50
Quality
Market Cap
$1.79B
Volume
809.22K
52W Range
$14.40 - $30.50
Target Price
$53.36
EPS Estimates Overview
| Current Quarter | $-1 | Next Quarter | $NA |
| Current Year | $-3.63 | Next Year | $-4.59 |
| QoQ Growth | NaN% | YoY Growth | -26.4% |
| 3Y EPS CAGR | -14.3% | Target Price | $53.36 |
| Consensus | Buy | Upside | +112.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CLDX | $25.17 | +2.1% | 809.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Celldex Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW